Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Beecham Group PLC, a prominent player in the pharmaceutical and healthcare industry, is headquartered in Great Britain. Founded in the early 19th century, the company has evolved significantly, marking key milestones in its journey towards becoming a leader in the sector. With a strong presence in Europe and North America, Beecham Group focuses on developing innovative healthcare solutions, including prescription medications and over-the-counter products.
Renowned for its commitment to quality and research, Beecham Group offers a diverse range of core products that cater to various health needs, setting itself apart through unique formulations and effective treatments. The company has achieved notable market position, recognised for its contributions to public health and its ongoing dedication to advancing medical science.
+58 vs industry average
Beecham Group PLC’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has typical carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Beecham Group PLC yet.
Beecham Group PLC, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of GSK plc, and any climate commitments or targets are inherited from its parent organization.
GSK plc has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, CDP participation, and RE100 membership, all of which are cascaded to Beecham Group PLC at a cascade level of 5. However, specific reduction targets or achievements for Beecham Group PLC are not detailed in the available data.
As part of its corporate family, Beecham Group PLC aligns with GSK's broader sustainability goals, which focus on reducing carbon emissions across all scopes. The lack of specific emissions data suggests that Beecham Group PLC is in the process of developing its own reporting framework or may rely on GSK's established metrics for its climate strategy.
No climate goals have been disclosed for Beecham Group PLC yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Beecham Group PLC yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more